FDA Inspection 1316574 — Grifols Laboratory Solutions Inc
The FDA completed an inspection of Grifols Laboratory Solutions Inc on May 7, 2026 in San Marcos, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 7, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- San Marcos, TX (United States)